Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference25 articles.
1. Environmental risk factors for inhibitor development in children with haemophilia A: A case-control study;Santagostino;Br J Haematol,2005
2. Cellular immune responses in hemophilia: Why do inhibitors develop in some, but not all hemophiliacs?;White;J Thromb Haemost,2005
3. Inhibitor antibodies to factor VIII and factor IX: Management;Lusher;Semin Thromb Hemost,2000
4. Pharmacokinetics of recombinant activated factor VII (rFVIIa);Erhardtsen;Semin Thromb Hemost,2000
5. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors;Key;Thromb Haemost,1998
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recombinant Activated Factor VII, as a Remedy for Intractable Coagulopathy Following Massive Transfusion in a Case of Giant Cranial Neurofibroma;Archives of Neuroscience;2014-07-01
2. Factor VIII and IX Inhibitors in Hemophilia;Hemostasis and Thrombosis;2014-02-14
3. Key issues in inhibitor management in patients with haemophilia;BLOOD TRANSFUS-ITALY;2014
4. FEIBA versus NovoSeven in Hemophilia Patients with Inhibitors;Seminars in Thrombosis and Hemostasis;2013-09-08
5. Treatment of Inhibitors in Hemophilia B;Textbook of Hemophilia;2010-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3